Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,050 | 1,780 | 1,542 | 523 | 1,930 |
| Depreciation Amortization | 149 | 100 | 55 | 21 | 130 |
| Accounts receivable | 131 | 771 | -295 | -175 | -397 |
| Accounts payable and accrued liabilities | 202 | 213 | 240 | 126 | 19 |
| Other Working Capital | -124 | 1,029 | 289 | -382 | -870 |
| Other Operating Activity | 178 | -404 | 417 | 349 | 658 |
| Operating Cash Flow | $2,586 | $3,487 | $2,248 | $462 | $1,470 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,696 | 252 | -3 | -1 | -5 |
| PPE Investments | -606 | -526 | -236 | -8 | -160 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -25 |
| Investing Cash Flow | $-8,303 | $-274 | $-239 | $-9 | $-190 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,595 | 14,490 | N/A | N/A | N/A |
| Other Financing Activity | -1,885 | -2,051 | -210 | -6 | -510 |
| Financing Cash Flow | $12,710 | $12,439 | $-210 | $-6 | $-510 |
| Beginning Cash Position | 2,462 | 2,462 | 2,462 | 2,462 | 1,690 |
| End Cash Position | 9,454 | 18,114 | 4,261 | 2,909 | 2,460 |
| Net Cash Flow | $6,993 | $15,652 | $1,799 | $447 | $760 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,586 | 3,487 | 2,248 | 462 | 1,470 |
| Capital Expenditure | -606 | -526 | -236 | -8 | -192 |
| Free Cash Flow | 1,979 | 2,961 | 2,012 | 455 | 1,278 |